Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017

June 8, 2017

Overview

Altaris Capital Partners announced its majority investment in Chemical Computing Group (CCG) on June 8, 2017.

Altaris is an investment firm which focuses on the healthcare industry.

CCG, headquartered in Montreal, Canada, is a provider of molecular design software for pharmaceutical, chemical and material industries.

Significance

Adds to Altaris’s $2.4 billion portfolio of equity capital.

CCG’s software platform, the Molecular Operating Environment (MOE), streamlines drug discovery and chemical engineering processes by allowing researchers to visualize and predict molecular properties and interactions.

Crosstree’s Role

Financial advisor to Chemical Computing Group.

Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017